CellCarta

The quality and rigor of your early-stage programs determines the success of your therapeutic development. Our California laboratory helps teams generate insights quickly and confidently. Get the insights your early-stage program needs, fast: buff.ly/McEpRqm

Don't miss the 3rd annual CellCarta Connect Challenge event in Shanghai, on May 20th. This scientific symposium brings together leading scientists and clinicians at the intersection of oncology, biomarkers, and diagnostics. Register today 👉buff.ly/UsUnac3

We are proud to announce the 2025 recipient of the Bob Fritzen Memorial Award, created in memory of our colleague as a tribute to his commitment to our core values: Trust & Respect, Passion & Perseverance, and Customer Excellence. Through this, we continue to honor Bob’s impact.

When a biotech sponsor needed two brand-new multiplex immunofluorescence assays developed, validated, and clinically tested against a hard conference deadline, our California laboratory team delivered, ahead of schedule. Read the full case study here: buff.ly/DkSaJdo

The CellCarta team is heading to Chicago for ASCO! If you'll be there, make sure to book a meeting with the team to learn how we can support your programs from early stages to CDx development. Book a meeting with the team here: cellcarta.com/explore/confer…

🤝 CellCarta and Leica Biosystems China have partnered to help make CDx development in China faster and more coordinated. Learn more about the partnership: buff.ly/dvfpWxw

Don't miss the 3rd annual CellCarta Connect Challenge event in Shanghai , on May 20th. This scientific symposium brings together leading scientists and clinicians at the intersection of oncology, biomarkers, and diagnostics. Register today 👉cellcarta.cn/event/2?utm_so…

Our team had a great time at TRI-CON! We presented our innovative CDx bridge model, designed to help biopharma teams accelerate companion diagnostic development with faster, more cost-effective strategies. Interested? Connect with our team 👉 cellcarta.com/contact/?utm_s…

Innovation that anticipates your needs. From routine assays to complex studies, our immunologists are trusted by start-ups and large pharma to get the data you need. 👨‍🔬👩‍🔬Get started: buff.ly/AwtEnEL

Last week, CellCarta celebrated Medical Laboratory Week! During lab week we honor the incredible contributions of our lab professionals, who play a critical role in advancing patient care.Here’s to you, our lab heroes! #LabWeek2026 #PrecisionMedecine

Attending TRI-CON? Don't miss the introduction of our innovative hybrid model designed to deliver speed and flexibility in precision medicine CDx. Interested in learning more? Reach out to our team to see how we can support your CDx development. cellcarta.com/contact/?utm_s…

The #ADC field is expanding fast, and so is the list of biomarkers driving it. That's where our California laboratory comes in, actively expanding our IHC and spatial biology assay portfolio to keep pace with the evolving ADC landscape. Learn more: buff.ly/IupadFG

Think you’ve got what it takes to top the leaderboard? 🎮 Swing by Booth #4647 and prove it! Ready, set, game on! 💥 #AACR2026

When it comes to flow cytometry data analysis software, we know what matters: making it fast and easy to use. Whether you have a few tubes, dozens of 384-well plates, or multi-gigabyte FCS files, CellEngine is ready to make analysis easier. Try it today! buff.ly/P2xTqHt

#AACR2026 is starting on April 17th! Are you heading to San Diego? We have two posters, presented by Pieter Mestagh, and a team of experts will be at Booth #4647, ready to discuss how we can support your therapeutic programs. Book a meeting 👩‍🔬👨‍🔬 buff.ly/71eAJM3

The CellCarta team is at WRIB! Don't miss our immunology experts - they're excited to discuss how our scientific and regulatory expertise can accelerate your therapeutic programs, from early stages through to CDx development. Stop by Booth #13!

Our immune monitoring experts are heading to #WRIB2026! Make sure to connect with the team at Booth #13. We have a slate of exciting posters and presentations! Reach out to the team today to see how we can apply them to your programs. buff.ly/ttYMGWn

Most study delays don’t come out of nowhere. They build until it becomes a crisis. Are your Phase 1, 2, or 3 studies in danger of delay due to sample management issues? Book a rescue study intake meeting 👉 buff.ly/0UvgMoA #CentralLab #SampleManagement #RiskMitigation

CellCarta and Pillar Biosciences Announce Multi-Year Global Strategic Partnership to Expand Rapid, Decentralized Tumor Profiling for Oncology Clinical Trials. Read the Full Announcement: buff.ly/JxNVUM7

CellCarta is heading to #AACR2026! Drop by booth #4647, and be sure to catch our posters. We partner with therapeutic teams to generate reliable data that supports complex clinical development. Book a meeting to learn how we can accelerate your programs👉 buff.ly/ttYMGWn